James S. Scibetta, Chief Financial Officer at Pacira Pharmaceuticals, Inc. (PCRX), bought 5,000 shares at $7.04 ($35K) on 2011-02-15, disclosed to the SEC on 2011-02-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCRX | SELL | 2017-06-07 | $170K | — | Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |